The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
A high pretreatment ALI value was associated with improved survival and disease control in u-HCC patients receiving Atez/Bev, underscoring its potential utility as a prognostic marker for clinical management and further studies.
Authors
- Shinji Shimoda
- Makoto Naganuma (ORCID: https://orcid.org/0000-0002-4244-3243)
- H Kato (ORCID: https://orcid.org/0000-0003-1055-4405)
- Ei Itobayashi (ORCID: https://orcid.org/0000-0003-0475-2819)
- Hoang Hai Duong (ORCID: https://orcid.org/0009-0006-9436-7939)
- Hisashi Kosaka (ORCID: https://orcid.org/0000-0002-2926-9973)
- Gozo Kiguchi (ORCID: https://orcid.org/0000-0003-2185-3275)
- Kyoko Inoue
- Fujimasa Tada (ORCID: https://orcid.org/0009-0007-3964-5876)
- Hideyuki Matsushima (ORCID: https://orcid.org/0000-0002-0406-9756)
- Văn Đức Nguyễn (ORCID: https://orcid.org/0000-0003-1414-4032)
- Kosuke Matsui (ORCID: https://orcid.org/0000-0002-7274-0177)
- Hidekazu Yamamoto
- Shunsuke Shiba
- Kengo Yoshii
- Masaki Kaibori
- Takuya Ohigashi
- Thanh Tung Lai
- Toshifumi Tada
- Takashi Yamaguchi
- Joji Tani
- Takeshi Hatanaka
- Atsushi Hiraoka
- Hidenori Toyoda
- Moriyasu Takada
- Takashi Kumada
Institutions
- Kansai Medical University (JP)
- Vietnam National University, Hanoi (VN)
- Hanoi Medical University (VN)
- Kagawa University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Ogaki Municipal Hospital (JP)
- Gunma Saiseikai Maebashi Hospital (JP)
- Himeji Red Cross Hospital (JP)
- Asahi General Hospital (JP)
- Ehime Prefectural Central Hospital (JP)
- Gifu Kyoritsu University (JP)
- VNU University of Science (VN)
Publication Details
- Journal
- Hepatology Research
- Published
- 2026-03-21
- DOI
- https://doi.org/10.1111/hepr.70152
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00